US Stock MarketDetailed Quotes

Marker Therapeutics (MRKR)

Watchlist
  • 1.400
  • -0.050-3.45%
Close Apr 24 16:00 ET
  • 1.393
  • -0.007-0.51%
Post 20:01 ET
23.34MMarket Cap-1.77P/E (TTM)

Marker Therapeutics (MRKR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.12%-12.01M
59.60%-1.9M
-328.47%-2.74M
47.35%-1.88M
-43.33%-5.5M
-5.50%-10.91M
-104.07%-4.7M
238.09%1.2M
12.37%-3.57M
-23.85%-3.84M
Net income from continuing operations
-13.35%-12.16M
55.62%-1.7M
13.41%-2M
-83.14%-4.02M
-85.81%-4.45M
23.60%-10.73M
-40.05%-3.84M
22.59%-2.31M
46.51%-2.19M
43.36%-2.39M
Change In working capital
8.68%-388K
66.37%-308.03K
-122.32%-770.49K
247.70%2.12M
5.97%-1.43M
-114.93%-424.87K
-413.60%-916.06K
77.98%3.45M
-1,071.48%-1.44M
-426.46%-1.52M
-Change in receivables
174.10%977.3K
118.46%295.75K
-99.47%9.18K
222.82%784.43K
86.39%-112.06K
-195.98%-1.32M
-69.64%-1.6M
4.99%1.75M
-289.64%-638.69K
-358.10%-823.65K
-Change in prepaid assets
-134.70%-175.03K
-31.44%467.97K
-30.38%151.87K
6.44%-437.3K
-602.80%-357.58K
-41.42%504.41K
-27.48%682.56K
37.96%218.12K
-70.16%-467.39K
95.10%71.12K
-Change in payables and accrued expense
-655.71%-2.17M
-18,942.11%-693.58K
-162.58%-931.54K
227.66%423.11K
-24.88%-963.06K
-36.26%389.61K
-99.09%3.68K
13,051.90%1.49M
-486.01%-331.42K
-793.69%-771.18K
-Change in other working capital
--974.8K
---378.18K
--0
----
----
----
----
----
----
----
Cash from discontinued investing activities
0
0
0
0
0
Operating cash flow
-10.12%-12.01M
59.60%-1.9M
-328.47%-2.74M
47.35%-1.88M
-43.33%-5.5M
33.64%-10.91M
-98.65%-4.7M
206.21%1.2M
49.44%-3.57M
34.83%-3.84M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-34.20%9.86M
0
579,787.30%9.86M
-99.78%100
-98.97%505
1,256.54%14.99M
289,985.90%14.9M
-99.65%1.7K
5,960.60%44.61K
-92.08%49.1K
Net common stock issuance
-33.93%9.86M
--0
--9.86M
----
----
1,371.37%14.93M
--14.89M
--0
--36.9K
--0
Proceeds from stock option exercised by employees
-99.03%605
--0
--0
-98.70%100
-98.97%505
-31.30%62.16K
-28.76%3.66K
-97.99%1.7K
946.74%7.7K
--49.1K
Cash from discontinued financing activities
Financing cash flow
-34.20%9.86M
--0
579,787.30%9.86M
-99.78%100
-98.97%505
1,256.54%14.99M
289,985.90%14.9M
-99.65%1.7K
5,960.60%44.61K
-92.08%49.1K
Net cash flow
Beginning cash position
27.01%19.19M
110.49%18.94M
51.46%11.81M
20.93%13.69M
27.01%19.19M
28.26%15.11M
-48.50%9M
-56.96%7.8M
76.89%11.32M
28.26%15.11M
Current changes in cash
-152.67%-2.15M
-118.64%-1.9M
494.40%7.13M
46.69%-1.88M
-45.17%-5.5M
22.58%4.08M
531.45%10.19M
285.01%1.2M
-130.06%-3.52M
29.60%-3.79M
End cash Position
-11.20%17.04M
-11.20%17.04M
110.49%18.94M
51.46%11.81M
20.93%13.69M
27.01%19.19M
27.01%19.19M
-48.50%9M
-56.96%7.8M
76.89%11.32M
Free cash flow
-10.12%-12.01M
59.60%-1.9M
-328.47%-2.74M
47.35%-1.88M
-43.33%-5.5M
33.64%-10.91M
-98.65%-4.7M
206.21%1.2M
49.44%-3.57M
34.83%-3.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.12%-12.01M59.60%-1.9M-328.47%-2.74M47.35%-1.88M-43.33%-5.5M-5.50%-10.91M-104.07%-4.7M238.09%1.2M12.37%-3.57M-23.85%-3.84M
Net income from continuing operations -13.35%-12.16M55.62%-1.7M13.41%-2M-83.14%-4.02M-85.81%-4.45M23.60%-10.73M-40.05%-3.84M22.59%-2.31M46.51%-2.19M43.36%-2.39M
Change In working capital 8.68%-388K66.37%-308.03K-122.32%-770.49K247.70%2.12M5.97%-1.43M-114.93%-424.87K-413.60%-916.06K77.98%3.45M-1,071.48%-1.44M-426.46%-1.52M
-Change in receivables 174.10%977.3K118.46%295.75K-99.47%9.18K222.82%784.43K86.39%-112.06K-195.98%-1.32M-69.64%-1.6M4.99%1.75M-289.64%-638.69K-358.10%-823.65K
-Change in prepaid assets -134.70%-175.03K-31.44%467.97K-30.38%151.87K6.44%-437.3K-602.80%-357.58K-41.42%504.41K-27.48%682.56K37.96%218.12K-70.16%-467.39K95.10%71.12K
-Change in payables and accrued expense -655.71%-2.17M-18,942.11%-693.58K-162.58%-931.54K227.66%423.11K-24.88%-963.06K-36.26%389.61K-99.09%3.68K13,051.90%1.49M-486.01%-331.42K-793.69%-771.18K
-Change in other working capital --974.8K---378.18K--0----------------------------
Cash from discontinued investing activities 00000
Operating cash flow -10.12%-12.01M59.60%-1.9M-328.47%-2.74M47.35%-1.88M-43.33%-5.5M33.64%-10.91M-98.65%-4.7M206.21%1.2M49.44%-3.57M34.83%-3.84M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow ----------------------0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -34.20%9.86M0579,787.30%9.86M-99.78%100-98.97%5051,256.54%14.99M289,985.90%14.9M-99.65%1.7K5,960.60%44.61K-92.08%49.1K
Net common stock issuance -33.93%9.86M--0--9.86M--------1,371.37%14.93M--14.89M--0--36.9K--0
Proceeds from stock option exercised by employees -99.03%605--0--0-98.70%100-98.97%505-31.30%62.16K-28.76%3.66K-97.99%1.7K946.74%7.7K--49.1K
Cash from discontinued financing activities
Financing cash flow -34.20%9.86M--0579,787.30%9.86M-99.78%100-98.97%5051,256.54%14.99M289,985.90%14.9M-99.65%1.7K5,960.60%44.61K-92.08%49.1K
Net cash flow
Beginning cash position 27.01%19.19M110.49%18.94M51.46%11.81M20.93%13.69M27.01%19.19M28.26%15.11M-48.50%9M-56.96%7.8M76.89%11.32M28.26%15.11M
Current changes in cash -152.67%-2.15M-118.64%-1.9M494.40%7.13M46.69%-1.88M-45.17%-5.5M22.58%4.08M531.45%10.19M285.01%1.2M-130.06%-3.52M29.60%-3.79M
End cash Position -11.20%17.04M-11.20%17.04M110.49%18.94M51.46%11.81M20.93%13.69M27.01%19.19M27.01%19.19M-48.50%9M-56.96%7.8M76.89%11.32M
Free cash flow -10.12%-12.01M59.60%-1.9M-328.47%-2.74M47.35%-1.88M-43.33%-5.5M33.64%-10.91M-98.65%-4.7M206.21%1.2M49.44%-3.57M34.83%-3.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More